Indication: Oral Mucositis

ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419) – Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer

Squamous Cell Carcinoma of head & neck

Sub-indication: Therapy trial to reduce severe oral mucositis

Line of Therapy: Newly Diagnosed

Principal Investigator: Jaspreet Grewal, M.D.
Norton Cancer Institute

Sponsor: Galera Therapeutics, Inc

Learn more at ClinicalTrials.gov

Email for more information: Head&Neck-NCIResearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.